AbbVie Inc (ABBV)
NYSE · Healthcare · Drug Manufacturers - General
AbbVie Inc is a Healthcare company with a market capitalization of $439.97B, a trailing P/E ratio of 70.3, and a dividend yield of 2.03%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | July 31, 2026 | $3.65 | $3.64 | +0.3% |
| Q1 2026 | April 29, 2026 | $2.65 | $2.67 | -0.8% |
| Q4 2025 | February 4, 2026 | $2.71 | $2.65 | +2.3% |
| Q3 2025 | October 31, 2025 | $1.86 | $1.78 | +4.5% |
| Q2 2025 | July 31, 2025 | $2.97 | $2.91 | +2.1% |
| Q1 2025 | April 25, 2025 | $2.46 | $2.40 | +2.5% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 22,632,412 | 1.28% | 3.5 | +3.4% |
| June 30, 2026 | 21,899,078 | 1.23% | 1.8 | -6.6% |
| June 15, 2026 | 23,446,826 | 1.32% | 4.6 | +1.2% |
| May 29, 2026 | 23,158,744 | 1.31% | 4.3 | +2.5% |
| May 15, 2026 | 22,590,034 | 1.27% | 4.0 | +8.1% |
| April 30, 2026 | 20,907,964 | 1.18% | 2.7 | -4.3% |
| April 15, 2026 | 21,845,453 | 1.23% | 3.7 | +8.6% |
| March 31, 2026 | 20,125,180 | 1.13% | 2.5 | -19.9% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is AbbVie Inc's market cap?
As of August 13, 2026, AbbVie Inc (ABBV) has a market capitalization of $439.97B.
What is AbbVie Inc's P/E ratio?
AbbVie Inc trades at a trailing price-to-earnings (P/E) ratio of 70.3. Its forward P/E is 17.7.
Does AbbVie Inc pay a dividend?
Yes — AbbVie Inc pays a dividend yielding 2.03%, an annual payout of $6.83 per share.
What sector is ABBV in?
AbbVie Inc is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is AbbVie Inc's short interest?
As of the July 15, 2026 FINRA settlement, 22,632,412 ABBV shares were sold short, or 1.28% of shares outstanding. Days to cover: 3.5. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was AbbVie Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), AbbVie Inc reported revenue of $61.16B and net income of $4.23B.
Ask your own questions about ABBV
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.